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ABSTRACT
Introduction: Pain and frailty are prevalent
conditions in the older population. Many
chronic diseases are likely involved in their
origin, and both have a negative impact on
quality of life. However, few studies have anal-
ysed their association.
Methods: In light of this knowledge gap, 3577
acutely hospitalized patients 65 years or older
enrolled in the REPOSI register, an Italian net-
work of internal medicine and geriatric hospital
wards, were assessed to calculate the frailty
index (FI). The impact of pain and some of its
characteristics on the degree of frailty was
evaluated using an ordinal logistic regression
model after adjusting for age and gender.
Results: The prevalence of pain was 24.7%, and
among patients with pain, 42.9% was regarded
as chronic pain. Chronic pain was associated
with severe frailty (OR = 1.69, 95% CI
1.38–2.07). Somatic pain (OR = 1.59, 95% CI
1.23–2.07) and widespread pain (OR = 1.60,
95% CI 0.93–2.78) were associated with frailty.
Osteoarthritis was the most common cause of
chronic pain, diagnosed in 157 patients
(33.5%). Polymyalgia, rheumatoid arthritis and
other musculoskeletal diseases causing chronic
pain were associated with a lower degree of
frailty than osteoarthritis (OR = 0.49, 95%CI
0.28–0.85).
Conclusions: Chronic and somatic pain nega-
tively affect the degree of frailty. The duration
and type of pain, as well as the underlying dis-
eases associated with chronic pain, should be
evaluated to improve the hospital management
of frail older people.
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Key Summary Points
Why carry out this study?
Frailty and pain are conditions in which
prevalence increases with age.
Many chronic diseases, especially those
related to the musculoskeletal system and
connective tissue, are involved in the
origin of both frailty and pain.
This paper investigates the relation
between pain and frailty in hospitalized
older patients.
What was learned from the study?
Chronic, widespread and somatic pain
were negatively associated with frailty.
The accurate assessment of pain and its
therapeutic treatment should be evaluated
to improve the management of frail
hospitalized older people.
DIGITAL FEATURES
This article is published with digital features to
facilitate understanding of the article. To view
digital features for this article go to https://doi.
org/10.6084/m9.figshare.12982520.
INTRODUCTION
Age is frequently associated with pain and
frailty. Chronic pain is clinically common,
being present in about 66% of persons over the
age of 65 years and mainly in women, who are
affected three times as frequently as men [1–3].
Pain often presents as a recurrent symptom
associated with acute and chronic inflammatory
processes such as rheumatic and degenerative
diseases. Among these, low back pain is the
most common, affecting 33% of older people.
Osteoarthritis involves major joints in about
12% of the world population, and rheumatoid
arthritis is diagnosed in about 1–2% [4]. Pain is
also a common symptom accompanying dif-
ferent chronic diseases such as cancer, diabetes,
neurodegenerative diseases, and liver, renal and
cardiovascular diseases, their common denom-
inators being the presence of chronic pain and
advanced age.
Chronic pain impairs quality of life and the
ability to maintain an independent lifestyle,
productivity and social relationships [5, 6]; thus
older people often experience mood and anxi-
ety disorders [7, 8]. Zis and collaborators
showed that about 13% of older adults suffered
from both major depression and chronic pain
simultaneously, although this prevalence may
vary in different populations, and the authors
highlight how the two conditions might be risk
factors for each other [9]. In turn, depression
increases the perception of pain, thus triggering
a vicious circle, suggesting a possible role of
neuroinflammation as a common pathogenic
factor for the development of both chronic pain
and depression [9]. Apart from depression,
many other causes and consequences of chronic
pain share common mechanisms with the
development of frailty [10].
Frailty is an age-related syndrome due to a
multidimensional process leading to increased
vulnerability, reduced ability to respond to
stressors, adverse health outcomes and also
death [12–15]. In older adults, persistent pain
might lead to a loss of physiological reserves
and impaired mobility, thus contributing to the
likelihood of frailty [11]. There is still ongoing
debate regarding the most suitable operational
definition and assessment instruments for use
in clinical practice to define frailty. The frailty
phenotype described by Fried, which is based on
five criteria related to compromised physical
performance [12], and the frailty index (FI)
based on age-related accumulation of deficits
proposed by Rockwood and Mitnitski are the
most common [16]. Regardless of the method,
frailty and pre-frailty increase in prevalence
with aging and are more frequent in women
[12, 17]. These features have similarities with
those of chronic pain, such that many causes
and effects of pain are embedded in the defini-
tion of frailty. There are at the moment only a
few studies that directly correlate pain with
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frailty [10, 18, 19], and they are confined to the
primary care setting. With the hypothesis that
early recognition and adequate management of
pain might be of crucial importance in hospi-
talized older adults in order to prevent or slow
frailty, the objective of this study was to evalu-
ate whether there was an association between
pain and frailty in a population of older patients




Data were obtained from REPOSI (REgistry
POlitherapy SIMI), an ongoing collaboration
between the Italian Society of Internal Medicine
(SIMI), IRCCS Fondazione Ca’ Granda Ospedale
Maggiore Policlinico and IRCCS ‘‘Mario Negri’’
Institute of Pharmacological Research involving
a network of more than 100 internal medicine
and geriatric hospital wards throughout Italy.
The REPOSI register enrols patients C 65 years
old acutely admitted to the participating wards
during four index weeks 3 months apart. Data
were initially obtained every 2 years (in 2010,
2012 and 2014), and are now collected yearly,
beginning in 2016. Greater detail is provided
elsewhere [15, 20]. The minimum data set
includes sociodemographic factors, laboratory
parameters, performance in activities of daily
living (ADL) according to the Barthel Index (BI)
[21], cognitive skills via the Short Blessed Test
(SBT) [22], patterns of co-morbidities and their
severity according to the Cumulative Illness
Rating Scale (CIRS) [23], and drugs prescribed
on admission, during hospital stay and at dis-
charge. The study was conducted according to
Good Clinical Practice guidelines and the Dec-
laration of Helsinki. The study was approved by
the Ethical Committee of the IRCCS Ca’ Granda
Maggiore Policlinico Hospital Foundation of
Milan and by the ethics committees of the
participating centres (Supplementary Material).
All patients provided signed informed consent.
Pain and Frailty Assessment
Patients enrolled from 2012 onward were eligi-
ble for the present analysis, because in previous
REPOSI runs, no information on pain was col-
lected. Patients with all the information avail-
able for the computation of the frailty index
were assessable for the present analysis.
Frailty was measured according to the frailty
index previously published within the frame-
work of the REPOSI register [24], and based
upon the procedure outlined by Searle [25]. The
index includes 34 items related to nutrition
using the body mass index (BMI), ability to
perform activities of daily living (BI), cognition
(SBT), mood (e.g. diagnosis of depression and
anxiety), laboratory parameters (e.g. hae-
moglobin, platelets, white blood cells, crea-
tinine clearance) and main chronic diseases
reported in the CIRS (e.g. severity of hyperten-
sion, heart failure, ischaemic heart disease,
stroke, diabetes, dyslipidaemias, thyroiditis,
chronic obstructive pulmonary disease [COPD],
kidney failure [CKD], upper and lower gas-
trointestinal diseases, liver disease, tumours,
musculoskeletal diseases, Parkinson disease and
psychiatric disorders). Patients were stratified
into three groups according to their increasing
degree of frailty: not frail (F0), moderately frail
(F1) and severely frail (F2). The cut-off values
were assessed according the 33th and 67th
percentiles of the FI distribution.
Pain and some of its characteristics, includ-
ing its temporal duration (acute or chronic),
type (somatic, visceral, neuropathic), localiza-
tions (localized, widespread), causes and inten-
sity (ranked from 0 to 10 according to the
Numeric Rating Scale, NRS), were self-reported
by patients and assessed at the moment of
hospital admission.
Statistical Analysis
Data were summarized as frequencies (%),
medians and interquartile ranges (IQR), or
means and standard deviations (SD) as appro-
priate. A proportional odds ordinal logistic
regression model (POM) was used to assess
whether pain and its characteristics were
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associated with increasing severity of frailty. In
the ordinal regression model, the response
variable was the severity of frailty assessed by
the three tiers of the FI introduced above, and
all models were adjusted for sex and age.
In the ordinal regression model, the fre-
quencies of each response category (e.g. F2),
and of those above (F1/F2), were in turn con-
sidered and compared with the frequencies of
those below (F1/F0 or F0), so that two separate
comparisons were obtained. POM assumes that
the effect of any covariate is the same across all
comparisons, so that only one set of regression
coefficients (and therefore only one odds ratio
for each predictor) should be estimated.
Accordingly, the regression model can be
expressed as:
log
P Y  jjxð Þ
P Y\jjxð Þ
 
¼ aj þ x0b:
The POM assumption was checked by the
score test and graphical methods. Results were
expressed as odds ratio (OR) and 95%
confidence interval (CI). The analysis was
performed using SAS version 9.4 software (SAS
Institute Inc., Cary, NC, USA).
RESULTS
Among 4827 patients enrolled in the REPOSI
register since 2012, 3577 (74.1%) were assess-
able for the computation of the FI. The sample
was well balanced for gender, with a mean age
(SD) of 79.1 (7.6) years, and the FI distribution
was positively skewed, with a mean of 0.27 and
SD of 0.14. In particular, 1177 were not frail
(F0), with a FI B 0.19, 935 were moderately frail
(F1), with a FI between 0.19 and 0.32, and 1169
were severely frail (F2), with FI[ 0.32. Frailty
increased with age, but with no significant dif-
ference between males and females after
adjustment for age.
Table 1 shows the characteristics of 3577
patients according to the degree of frailty.
Among patients, 884 (24.7%) suffered from
pain, and in particular 379 (42.9%) had chronic
pain. Somatic pain was the most common type
of pain occurring in 400 patients (45.2%).
Furthermore, 48 patients (5.5%) experienced
widespread pain, and among the others, 195
patients (22.3%) suffered from pain involving
two or more body sites, mainly the trunk and
lower limbs.
Table 2 shows the results from the ordinal
logistic regression model. In all the regression
models, the chi-square score test failed to reject
the null hypothesis of equal regression coeffi-
cients across response categories (p[ 0.25); thus
we may conclude that the proportional odds
assumption holds. After adjusting for sex and
age, there was an overall statistically significant
association between pain and frailty (OR = 1.33,
95% CI 1.16–1.54). Specifically only patients
suffering from chronic pain, but not those with
acute pain, were more likely to be moderately to
severely frail than those with no pain (OR =
1.69, 95% CI 1.38–2.07).
Somatic pain was associated with a higher
degree of frailty than all other types of pain
(OR = 1.60, 95% CI 1.22–2.07). Patients with
widespread pain tended to be frailer than those
suffering from localized pain (OR = 1.60, 95%
CI 0.93–2.78), regardless of the number or
specific sites involved. No relation was found
between pain intensity and frailty, either in the
overall population or in those with chronic
pain.
Musculoskeletal conditions were the most
common cause of persistent pain, particularly
osteoarthritis, which accounted in our sample
for almost one third of the cases, followed by
rheumatoid arthritis and other rheumatic con-
ditions (18.0%). Cancer was the other most
frequent condition (Table 3). No relevant dif-
ference was found among the diseases leading
to chronic pain (Table 4), but a lower degree of
frailty was found in patients with pain caused
by rheumatic conditions (OR = 0.49, 95%CI
0.28–0.85).
DISCUSSION
This study investigated the association between
pain and frailty along with its characteristics in
a large sample of acutely hospitalized older
patients. Despite the rather low prevalence of
patients reporting pain, the results allow us to
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Table 1 Main characteristics at hospital admission of 3577 patients split by their levels of frailty (F0, F1, F2)
F0 (n = 1177) F1 (n = 935) F2 (n = 1169) Missing
Sex
Male 620 (52.7) 615 (50.0) 532 (45.5)
Female 557 (47.3) 616 (50.0) 637 (54.5)
Age, mean (SD 75.9 (6.9) 78.5 (7.0) 81.5 (7.3)
65–74 533 (45.3) 378 (30.7) 221 (18.9)
75–84 497 (42.2) 579 (47.0) 506 (43.3)
C 85 147 (12.5) 274 (22.3) 442 (37.8)
Geographic area
North 656 (56.0) 671 (54.7) 725 (62.4)
Center 216 (18.5) 225 (18.4) 162 (14.0)
South 298 (25.5) 330 (26.9) 274 (23.6)
REPOSI year
2012 385 (32.7) 347 (28.2) 323 (27.6)
2014 279 (23.7) 261 (21.2) 251 (21.5)
2016 143 (12.2) 205 (16.6) 203 (17.4)
2017 210 (17.8) 216 (17.6) 205 (17.5)
2018 160 (13.6) 202 (16.4) 187 (16.0)
Living condition 123
Alone 297 (26.1) 308 (26.1) 220 (19.4)
Family 751 (65.9) 774 (65.5) 719 (63.5)
Other 43 (3.8) 64 (5.4) 111 (9.8)
Nursing home 48 (4.2) 36 (3.0) 83 (7.3)
Pain 251 (21.5) 319 (26.1) 314 (27.2) 29
Durationa 109
Acute 146 (62.7) 146 (50.9) 146 (49.2)
Chronic 87 (37.3) 141 (49.1) 151 (50.8)
Typea 85
Somatic 87 (38.5) 144 (51.1) 169 (58.1)
Visceral 81 (35.8) 83 (29.4) 68 (23.4)
Neuropathic 31 (13.7) 38 (13.5) 35 (12.0)
Other 27 (12.0) 17 (6.0) 19 (6.5)
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evaluate how pain and its characteristics are
negatively associated with increasing frailty.
Only a few studies have previously evaluated
the relationship between pain and frailty
[18, 19, 26, 27].
Pain and frailty present important differ-
ences. Pain, defined by the International Asso-
ciation for the Study of Pain (IASP) as ‘‘an
unpleasant sensory and emotional experience
associated with tissue damage, actual or poten-
tial’’, is a subjective experience, generally con-
sidered a symptom of injury or disease. Frailty,
on the other hand, is a biological condition
derived from multiple clinical factors that
indicate a more or less deficient condition of
health. Our main finding was the association
between chronic but not acute pain and a
higher degree of frailty. The definition of
chronic pain is still controversial. Typically,
pain is considered chronic when it lasts or
recurs over a period of more than 3–6 months
[28, 29].
According to a more functional concept,
chronic pain is triggered and maintained by
biochemical and structural changes in the cen-
tral nervous system, including glial activation
and the onset of neuroinflammation, owing to
an intense release of nociceptive stimuli over a
long period of time [30, 31]. Notably, neuroin-
flammatory processes can be linked both to
Table 1 continued
F0 (n = 1177) F1 (n = 935) F2 (n = 1169) Missing
Intensity (NRS)a 24
Mild (1–3) 73 (30.0) 84 (26.8) 84 (27.4)
Moderate (4–6) 72 (29.6) 110 (35.0) 93 (30.3)
Severe (7–10) 96 (39.5) 119 (37.9) 129 (42.0)
Locationa 11
Widespread 9 (3.6) 19 (6.0) 20 (6.4)
1 184 (74.2) 230 (73.0) 216 (69.7)
2 35 (14.1) 51 (16.2) 53 (17.1)
C 3 20 (8.1) 15 (4.8) 21 (6.8)
Body sitea
Head and neck 20 17 21
Upper limbb 37 40 50
Trunkc 155 187 166
Lower limbd 60 93 104
Data are expressed as frequencies and percentages (%), unless otherwise specified. Quantile ranges in the definition of the
levels of frailty are: [0–0.19] for F0; [0.19–0.32] for F1; [0.32–1] for F2
NRS numeric rating scale
a Percentages of pain characteristics (duration, type, intensity, location and body site) refer to 884 patients with pain. Body
sites include:
b Shoulder, arm, forearm, hand
c Thorax, abdomen, beck
d Thigh, leg, foot
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chronic pain and to depression, often present in
these patients [9].
Persistent pain is typically the consequence
of the presence of chronic diseases capable of
generating persistent and intense stimuli. In our
study, chronic pain was indeed associated with
the type of underlying disease.
No significant differences in the frailty index
were found between osteoarthritis, cancer and
other less frequent diseases causing chronic
pain. Exceptions were polymyalgia, rheumatoid
arthritis and a few other musculoskeletal dis-
eases, that presented with a lower risk of severe
frailty than osteoarthritis (OR = 0.49). Further-
more, widespread rather than localized pain was
associated with increasing frailty, and somatic
rather than visceral and neuropathic pain was
associated with a higher degree of frailty. On
the other hand, the frailty index was not influ-
enced by the intensity of pain, ranked as mild,
moderate or severe [32, 33]. Surprised by this
finding, we chose to evaluate pain intensity
separately for chronic pain, but even this anal-
ysis failed to show a relationship with the frailty
index. This apparent contradiction reinforces
the view that the chronicity of pain rather than
Table 2 Results of ordinal logistic regression models
assessing the effect of pain and its characteristics on the
degree of frailty (lower frailty as the reference)
OR (95% CI)
A Sex (M vs F) 0.92 (0.82–1.05)
Age (5 years) 1.46 (1.40–1.52)
Pain (yes vs no) 1.33 (1.15–1.54)
B Sex (M vs F) 0.93 (0.82–1.05)
Age (5 years) 1.46 (1.40–1.52)
Duration (acute vs no) 1.13 (0.93–1.36)
Duration (chronic vs no) 1.69 (1.38–2.07)
C Sex (M vs F) 0.93 (0.72–1.25)
Age (5 years) 1.35 (1.24–1.48)
Intensity (moderate vs mild) 1.06 (0.77–1.46)
Intensity (severe vs mild) 1.19 (0.88–1.61)
D Sex (M vs F) 0.96 (0.73–1.25)
Age (5 years) 1.40 (1.27–1.54)
Type (somatic vs other) 1.60 (1.22–2.07)
E Sex (M vs F) 0.94 (0.73–1.22)
Age (5 years) 1.38 (1.27–1.51)
Location (spread vs localized) 1.60 (0.93–2.78)
OR odds ratio, 95% CI 95% confidence interval
Table 3 Causes of pain in 379 patients with chronic paina
Causes N (%) N
Osteoarthritis 125 (33.6)
Other musculoskeletal diseases 67 (18.0)




Bone diseases 34 (9.1)
Fractures 22
Osteopathy 12
Diseases with neuropathic components 11 (3.0)
Other diseases 82 (22.0)






ICD9-CM codes used in identifying causes of pain:
osteoarthritis: 696.0, 715(–719); spondylitis and column
diseases: 720–724; rheumatoid arthritis 714; polymyalgia:
710, 725–729; cancer: 140–239, V10; fractures: 733.1–9,
800–821, 905; osteoporosis and other osteopathies:
730–739, excl. 733.1–9; diseases with neuropathic com-
ponents: 053, 350, 356–357; diseases of the digestive sys-
tem: 520–579; vascular diseases: 395, 401, 413, 428,
443–444, 446–447, 453–454, 747; ulcer: 707; headache:
307, 784
a In seven patients the cause of pain was unknown
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its severity is the main determinant of the
degree of frailty.
With regard to pain generators, they were
mainly related to chronic conditions strongly
connected to chronic inflammatory processes,
often widespread with multiple body localiza-
tions. Rheumatic diseases and cancer, the most
frequent in our cases, are conditions associated
with long-lasting and systemic inflammation.
The high concentration of pro-inflammatory
molecules bind to nociceptors and determine
the sustained and continuous presence of
painful stimuli, causing on the one hand a sit-
uation of permanent and widespread pain and,
at the same time, the burden of progressing
systemic disease.
In order to break this chain, one goal is to
reduce the level of inflammation by means of
preventive or therapeutic methods effective for
both the cause (inflammation) and the effect
(pain) [34].
Because both pain and frailty negatively
affect quality of life in older people, better
recognition of chronic pain and its manage-
ment should become a target for intervention
that may help to avoid the worsening of frailty
in older hospitalized patients.
Limitations
This study on the relationship between pain
and frailty was based upon data collected within
the framework of a cross-sectional study. Even
though the available data allow for an accurate
assessment of the frailty index, data on pain and
its characteristics are likely to be under-re-
ported, with incomplete information, because
its assessment may be hampered when com-
munication problems exist, as is the case in
patients with severe cognitive impairment or
dementia. A more standardized and specifically-
driven data collection method is therefore
warranted, and only a prospective study would
be able to provide further insights on the nat-
ural history of frailty and to assess the potential
role of pain as a possible contributor to frailty.
Furthermore, at variance with previous reports,
we did not take into account physical frailty
and characteristics such as weakness and
exhaustion. Chronic conditions, such as mus-
culoskeletal diseases and mood disorders, often
leading to chronic pain, are also embedded in
the definition of the frailty index itself, thus
making it difficult to assess how they mediate
and modulate the relationship between pain
and frailty.
CONCLUSION
Chronic, diffuse and somatic pain associated
with long-term chronic diseases is the expres-
sion of inflammatory processes, and reasonably
affects at least in part the severity of frailty and
quality of life in hospitalized older adults with
multimorbidity. An accurate and more in-depth
evaluation of pain and the recognition of its
aetiology may help clinicians to manage these
frail patients with effective results.
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